Shamonki JM - Search Results

1

Microbial dysbiosis is associated with human breast cancer.

Xuan C, Shamonki JM, Chung A, Dinome ML, Chung M, Sieling PA, Lee DJ. Xuan C, et al. Among authors: shamonki jm. PLoS One. 2014 Jan 8;9(1):e83744. doi: 10.1371/journal.pone.0083744. eCollection 2014. PLoS One. 2014. PMID: 24421902 Free PMC article.

2

Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma.

Lardone RD, Plaisier SB, Navarrete MS, Shamonki JM, Jalas JR, Sieling PA, Lee DJ. Lardone RD, et al. Among authors: shamonki jm. Oncotarget. 2016 Mar 22;7(12):14415-28. doi: 10.18632/oncotarget.7361. Oncotarget. 2016. PMID: 26883106 Free PMC article.

3

Histological assessment of breast lesions identified exclusively by magnetic resonance.

O'Connor V, Arena E, Albright J, Brown N, O'Connor R, Chung M, DiNome M, Shamonki J. O'Connor V, et al. Am Surg. 2014 Oct;80(10):944-7. Am Surg. 2014. PMID: 25264635

4

Prognostic value of basal phenotype in HER2-overexpressing breast cancer.

Bagaria SP, Ray PS, Wang J, Kropcho L, Chung A, Sim MS, Shamonki JM, Martino S, Cui X, Giuliano AE. Bagaria SP, et al. Among authors: shamonki jm. Ann Surg Oncol. 2012 Mar;19(3):935-40. doi: 10.1245/s10434-011-2032-5. Epub 2011 Aug 31. Ann Surg Oncol. 2012. PMID: 21879270

5

Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?

Shamonki J, Chung A, Huynh KT, Sim MS, Kinnaird M, Giuliano A. Shamonki J, et al. Ann Surg Oncol. 2013 Dec;20(13):4137-44. doi: 10.1245/s10434-013-3191-3. Epub 2013 Aug 14. Ann Surg Oncol. 2013. PMID: 23943035

6

Assessment of DNA methylation status in early stages of breast cancer development.

van Hoesel AQ, Sato Y, Elashoff DA, Turner RR, Giuliano AE, Shamonki JM, Kuppen PJ, van de Velde CJ, Hoon DS. van Hoesel AQ, et al. Among authors: shamonki jm. Br J Cancer. 2013 May 28;108(10):2033-8. doi: 10.1038/bjc.2013.136. Epub 2013 May 7. Br J Cancer. 2013. PMID: 23652305 Free PMC article.

7

FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.

Ray PS, Wang J, Qu Y, Sim MS, Shamonki J, Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DS, Walter MA, Martens JW, Richardson AL, Giuliano AE, Cui X. Ray PS, et al. Cancer Res. 2010 May 15;70(10):3870-6. doi: 10.1158/0008-5472.CAN-09-4120. Epub 2010 Apr 20. Cancer Res. 2010. PMID: 20406990

8

Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study.

van Hoesel AQ, van de Velde CJ, Kuppen PJ, Liefers GJ, Putter H, Sato Y, Elashoff DA, Turner RR, Shamonki JM, de Kruijf EM, van Nes JG, Giuliano AE, Hoon DS. van Hoesel AQ, et al. Among authors: shamonki jm. Breast Cancer Res Treat. 2012 Aug;134(3):1103-14. doi: 10.1007/s10549-012-2038-0. Epub 2012 Apr 5. Breast Cancer Res Treat. 2012. PMID: 22476853

9

Personalizing breast cancer staging by the inclusion of ER, PR, and HER2.

Bagaria SP, Ray PS, Sim MS, Ye X, Shamonki JM, Cui X, Giuliano AE. Bagaria SP, et al. Among authors: shamonki jm. JAMA Surg. 2014 Feb;149(2):125-9. doi: 10.1001/jamasurg.2013.3181. JAMA Surg. 2014. PMID: 24306257

10

Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.

Ray PS, Bagaria SP, Wang J, Shamonki JM, Ye X, Sim MS, Steen S, Qu Y, Cui X, Giuliano AE. Ray PS, et al. Among authors: shamonki jm. Ann Surg Oncol. 2011 Dec;18(13):3839-47. doi: 10.1245/s10434-011-1657-8. Epub 2011 Mar 18. Ann Surg Oncol. 2011. PMID: 21424368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page